STEPHANIE WRENCHER: Open Payments
NPI 1467496588 · BUFORD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 75 payments from 27 companies in 2025. Trend: 2023 $1,859 · 2024 $821 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $309 |
| GENZYME CORPORATION | 6 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $119 |
| PFIZER INC. | 6 | $113 |
| Janssen Biotech, Inc. | 5 | $104 |
| ANI Pharmaceuticals, Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| SANOFI-AVENTIS U.S. LLC | 3 | $61 |
| Invivyd Inc | 2 | $59 |
| UCB, Inc. | 2 | $49 |
Products named: Wegovy, DUPIXENT, TREMFYA, ELIQUIS, PURIFIED CORTROPHIN GEL, OFEV, TZIELD, PEMGARDA.
Industry payments across GA — which companies pay providers there.
